In This Section

Program: Sunday, February 23

Monday, Feb. 24 Tuesday, Feb. 25 Wednesday, Feb. 26

sunday, february 23

  • Educational Sessions 1-2       
    • Detection of Tumor-Reactive T Cells
    • Strategies to Overcome Manufacturing Challenges for Cell-based Therapy                                                                                                      
  • Educational Sessions 3-4
    • Spatial Organization of Immune Cells and Treatment with Immunotherapy
    • T-Cell Therapies: Advances and Challenges
  • Welcome and Keynote Session 1
Sunday, February 23

EDUCATIONAL SESSIONS 1 AND 2

3:30-4:50 p.m. | CME Eligible

educational session 1: detection of tumor-reactive t cells

Session Chair: Stephen Schoenberger, La Jolla Institute for Immunology, La Jolla, California

  • 3:35 p.m.
    Giacomo Oliveira, Harvard Medical School, Cambridge, Massachusetts
  • 3:55 p.m.
    Cristina Puig Saus, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California
  • 4:15 p.m.
    Stephen Schoenberger
  • 4:35 p.m. | Discussion / Q&A

EDUCATIONAL SESSION 2: Strategies to Overcome Manufacturing Challenges for Cell-Based Therapy

Session Chair: Marc Better, Pharmefex, Bellevue, Washington

  • 3:35 p.m.
    Michal Besser, Rabin Medical Center, Petach Tilva, Israel
  • 3:50 p.m.
    Isabelle Rivière, Takeda, Cambridge, Massachusetts
  • 4:05 p.m.
    Brian Shy, University of California, San Francisco, California
  • 4:15 p.m.
    Fabian Gerlinghaus, Cellares, San Francisco, California
  • 4:35 p.m. | Discussion / Q&A

break
4:50-5:20 P.M.

EDUCATIONAL SESSIONS 3 AND 4

5:20-6:30 p.m. | CME Eligible

EDUCATIONAL SESSION 3: Spatial Organization of Immune Cells and Treatment with Immunotherapy

Session Chair: Nir Hacochen, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts

  • 5:25 p.m.
    Nir Hacohen
  • 5:45 p.m.
    Stefani Spranger, Koch Institute for Integrative Cancer Research at MIT, Boston, Massachusetts
  • 6:06 p.m.
    Robert D. Schreiber, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  • 6:25 p.m. | Discussion / Q&A

EDUCATIONAL SESSION 4: T-cell Therapies: Advances and Challenges

Session Chair: Yvonne Y. Chen, University of California, Los Angeles, California

  • 5:25 p.m.
    Speaker to be announced
  • 5:45 p.m.
    Yvonne Y. Chen
  • 6:06 p.m.
    Aude G. Chapuis, Fred Hutchinson Cancer Center, Seattle, Washington
  • 6:25 p.m. | Discussion / Q&A

WELCOME AND keynote SESSION 1

6:50-8 p.m. | CME Eligible

  • 7:05 p.m. | Celebrating 30 years of CTLA-4
    James P. Allison, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • 7:35 p.m.
    Arlene H. Sharpe, Harvard Medical School, Boston, Massachusetts

Opening reception

8-10 p.m.